Invion Limited announced Mr. Brett Heading's resignation from the Board of Directors, and Dr. Greg Collier has been appointed as Interim Executive Chair of the Board. Dr. Collier has served as Managing Director and CEO of Invion since 3 May 2013. His transition to interim Executive Chair will take immediate effect.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 AUD | -9.09% | -9.09% | 0.00% |
05-08 | Invion Partners with Hanlim Pharma for Glioblastoma Treatment | MT |
03-05 | Invion's Anti-Cancer Drug Logs Postive Preclinical Trial Results | MT |
1st Jan change | Capi. | |
---|---|---|
0.00% | 21.3M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- IVX Stock
- News Invion Limited
- Invion Limited Announces Board Changes